2022
DOI: 10.1159/000522577
|View full text |Cite
|
Sign up to set email alerts
|

Evaluation of IL-1β and IL-6 Expression following EBNA-1 and BRLF-1 Peptide Treatment in Epstein-Barr Virus-Positive Multiple Sclerosis Patients

Abstract: Introduction: Epstein-barr virus (EBV/HHV-4) has been implicated in the pathogenesis of Multiple sclerosis (MS). This study was conducted to investigate the levels of pro-inflammatory cytokines IL-1β and IL-6 in healthy Epstein-Barr virus (EBV) carriers and MS patients with prior EBV infection in response to treatment with Epstein–Barr virus nuclear antigen 1 (EBNA-1) and Replication and transcription activator (BRLF-1/Rta) peptide antigens in whole blood cell culture to assess the cytokine expression across a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 40 publications
0
1
0
Order By: Relevance
“…Elevated levels of IL-1β and IL-6 have also been observed in patients with multiple sclerosis [ 79 , 80 ]. Peripheral blood cells taken from multiple sclerosis patients respond by secreting these cytokines upon stimulation with EBV antigens [ 76 , 81 ]. An in vitro study supports an upregulation of IL6 expression upon EBV infection [ 76 ].…”
Section: Discussionmentioning
confidence: 99%
“…Elevated levels of IL-1β and IL-6 have also been observed in patients with multiple sclerosis [ 79 , 80 ]. Peripheral blood cells taken from multiple sclerosis patients respond by secreting these cytokines upon stimulation with EBV antigens [ 76 , 81 ]. An in vitro study supports an upregulation of IL6 expression upon EBV infection [ 76 ].…”
Section: Discussionmentioning
confidence: 99%